Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2021 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Quetta XR | SPIMACO | Prolonged-release capsule | Jan 1, 2021 | Generic |
| Finate | Jamjoom Pharmaceuticals Factory Company | Capsule, hard | Jan 1, 2021 | Generic |
| Skyrizi 150 mg | AbbVie Deutschland GmbH & Co KG | Solution for injection | Jan 1, 2021 | Biological |
| Gizlan HCT | DAR ALDAWA | Film-coated tablet | Jan 1, 2021 | Generic |
| Kesimpta | NOVARTIS Pharma Stein AG | Solution for injection in pre-filled pen | Jan 1, 2021 | Biological |
| Tedalix | PT Bio Farma ( Persero ) | Suspension for injection | Jan 1, 2021 | Biological |
| Virad | Hetero Labs Limited Unit – III | Film-coated tablet | Jan 1, 2021 | Generic |
| Nefalgic | DELPHARM LILLE S.A.S. | Solution for injection | Jan 1, 2021 | Generic |
| Feromenta | SPIMACO | Chewable tablet | Jan 1, 2021 | Generic |
| Reblozyl | Patheon Italia S.P.A. | powder for solution for injection | Jan 1, 2021 | Biological |
| Water for injection | AL RAZI PHARMA INDUSTRIES FACTORY LTD | Intravenous infusion | Jan 1, 2021 | Generic |
| Reblozyl | Patheon Italia S.P.A. | powder for solution for injection | Jan 1, 2021 | Biological |
| Enzastik | Eugia Pharma Specialties Limited | Capsule, soft | Jan 1, 2021 | Generic |
| Keroz | Shilpa Medicare Ltd | Capsule, hard | Jan 1, 2021 | Generic |
| Neulasta Onpro | AMGEN MANUFACTURING LIMITED | Solution for injection in pre-filled syringe | Jan 1, 2021 | Biological |
| TRUMENBA | PFIZER | Suspension for injection in pre-filled syringe | Jan 1, 2021 | Biological |
| Carbimazole Macleods | Macleods Pharmaceuticals Limited | Tablet | Jan 1, 2021 | Generic |
| Proteomib | VENUS REMEDIES LIMITED | powder for solution for injection | Jan 1, 2021 | Generic |
| Veklury | GILEAD SCIENCES LIMITED (CORK) | Powder for concentrate for solution for infusion | Jan 1, 2021 | NCE |
| Glucophage XR | MERCK HEALTHCARE KGAA | Prolonged-release tablet | Jan 1, 2021 | NCE |
